Clinical trial
Glufosfamide With or Without Hydration in Treating Patients With Advanced…
NCT00005053 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00005053 |
|---|---|
| Title | Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer |
| Official title | Open Label Phase II Study on Glufosfamide Administered as a 60 Minute Infusion Every 3 Weeks in Advanced Pancreatic Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | glufosfamide |
| Enrollment | 35 |
| Start date | Dec 1, 1999 |
| Primary completion | Mar 1, 2001 |
| First posted | May 3, 2004 |
| Last update posted | Sep 24, 2012 |
| Countries | Denmark, France, Germany, Greece, Israel, Netherlands, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: